Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial

NCT01539239 is registered in ClinicalTrials.gov with Ivantis, Inc. as lead sponsor.

NCT NCT01539239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01539239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial
Lead sponsor
Ivantis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2020
Enrollment
1,143 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma